Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19,258Revenue (TTM) $M10,300Net Margin (%)2.5Altman Z-Score0.9
Enterprise Value $M33,821EPS (TTM) $0.5Operating Margin %7.9Piotroski F-Score3
P/E(ttm)70.6Beneish M-Score-2.7Pre-tax Margin (%)1.1Higher ROA y-yN
Price/Book1.610-y EBITDA Growth Rate %13.1Quick Ratio0.6Cash flow > EarningsY
Price/Sales1.85-y EBITDA Growth Rate %7.5Current Ratio0.8Lower Leverage y-yN
Price/Free Cash Flow11.1y-y EBITDA Growth Rate %-19.9ROA % (ttm)1.0Higher Current Ratio y-yN
Dividend Yield %--PEG9.4ROE % (ttm)2.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M535ROIC % (ttm)4.1Gross Margin Increase y-yN

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLDavid Einhorn 2016-09-30 Add1.06%$38.12 - $49.92
($44.46)
$ 35.99-19%Add 29.42%6,400,000
MYLJohn Paulson 2016-09-30 Reduce-0.1%$38.12 - $49.92
($44.46)
$ 35.99-19%Reduce -0.98%21,811,661
MYLVanguard Health Care Fund 2016-09-30 Add0.1%$38.12 - $49.92
($44.46)
$ 35.99-19%Add 4.23%29,148,837
MYLJoel Greenblatt 2016-09-30 Buy 0.01%$38.12 - $49.92
($44.46)
$ 35.99-19%New holding21,460
MYLMario Gabelli 2016-09-30 Add$38.12 - $49.92
($44.46)
$ 35.99-19%Add 14.37%16,012
MYLDavid Einhorn 2016-06-30 Add1.63%$38.62 - $48.8
($44.27)
$ 35.99-19%Add 71.11%4,945,000
MYLJohn Paulson 2016-06-30 Reduce-0.46%$38.62 - $48.8
($44.27)
$ 35.99-19%Reduce -5.60%22,028,061
MYLJoel Greenblatt 2016-06-30 Sold Out -0.44%$38.62 - $48.8
($44.27)
$ 35.99-19%Sold Out0
MYLVanguard Health Care Fund 2016-06-30 Add0.12%$38.62 - $48.8
($44.27)
$ 35.99-19%Add 4.82%27,965,385
MYLMario Gabelli 2016-06-30 Reduce$38.62 - $48.8
($44.27)
$ 35.99-19%Reduce -17.65%14,000
MYLDavid Tepper 2016-03-31 Sold Out -0.92%$41.42 - $54.09
($48.28)
$ 35.99-25%Sold Out0
MYLJoel Greenblatt 2016-03-31 Add0.44%$41.42 - $54.09
($48.28)
$ 35.99-25%Add 9178.19%837,728
MYLVanguard Health Care Fund 2016-03-31 Add0.25%$41.42 - $54.09
($48.28)
$ 35.99-25%Add 10.00%26,679,385
MYLJohn Paulson 2016-03-31 Add0.19%$41.42 - $54.09
($48.28)
$ 35.99-25%Add 2.38%23,335,861
MYLKeeley Asset Management Corp 2016-03-31 Sold Out -0.09%$41.42 - $54.09
($48.28)
$ 35.99-25%Sold Out0
MYLMario Gabelli 2016-03-31 Reduce$41.42 - $54.09
($48.28)
$ 35.99-25%Reduce -35.73%17,000
MYLDavid Einhorn 2015-12-31 Buy 2.86%$39.16 - $55.28
($48.35)
$ 35.99-26%New holding2,890,000
MYLDavid Tepper 2015-12-31 Add0.41%$39.16 - $55.28
($48.35)
$ 35.99-26%Add 81.62%853,749
MYLJohn Paulson 2015-12-31 Add0.29%$39.16 - $55.28
($48.35)
$ 35.99-26%Add 4.02%22,794,061
MYLVanguard Health Care Fund 2015-12-31 Add0.11%$39.16 - $55.28
($48.35)
$ 35.99-26%Add 4.26%24,253,075
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BRESCH HEATHER MCEO 2016-08-09Sell100,200$50-28.02view
MAROON JOSEPH C MDDirector 2016-06-03Buy1,670$44.95-19.93view
MAROON JOSEPH C MDDirector 2016-05-25Buy2,370$42.47-15.26view
Cindrich Robert JDirector 2016-05-25Buy1,190$42.47-15.26view
HIGGINS MELINA EDirector 2016-05-12Buy19,900$38.68-6.95view
HIGGINS MELINA EDirector 2016-05-06Buy100$38.69-6.98view
HIGGINS MELINA EDirector 2016-04-28Buy35,000$42.92-16.15view
COURY ROBERT JExecutive Chairman 2016-04-05Sell217,755$45.96-21.69view
MAROON JOSEPH C MDDirector 2016-03-31Buy4,337$46.36-22.37view
PARRISH MARK WDirector 2016-03-17Buy1,705$44-18.2view

Press Releases about MYL :

Quarterly/Annual Reports about MYL:

News about MYL:

Articles On GuruFocus.com
Weak Outlook on Mylan Nov 18 2016 
3 Health Industry Sectors Bound to Profit From a Trump Presidency Nov 11 2016 
Mylan Posts Loss Amid Investigation, Settlement Nov 10 2016 
Buy Health Care Now? It All Depends on the Election Nov 07 2016 
Allergan: Trading at a Low Earnings Multiple Nov 06 2016 
David Einhorn Converses on Range of Topics, Stocks With New York Times Editor Oct 20 2016 
The Pharmaceutical Sector Looks Attractive Oct 12 2016 
John Paulson’s Health Care Picks Plunge in Flat Year for Sector Oct 06 2016 
Lee Ainslie’s Top 3 New Holdings Aug 29 2016 
Swiss Generics Manufacturer Has Strong 1st Half of Year Aug 22 2016 

More From Other Websites
MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS... Dec 02 2016
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mylan... Dec 02 2016
Ontario health ministry to probe alleged Costco pharmacy kickbacks Dec 01 2016
Pharma execs weigh in on possible changes under Trump Dec 01 2016
Allergan CEO expects drug industry to face pricing heat from Trump Dec 01 2016
The EpiPen-maker's CEO knows who's responsible for soaring drug costs — and it's not her Dec 01 2016
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of... Dec 01 2016
Mylan CEO Hopes EpiPen Furor Leads To 'Price Transparency' Dec 01 2016
Trump May Be More ‘Vicious’ on Drug Prices, Pharma CEO Says Dec 01 2016
Mylan's Commitment to Stemming the Tide of HIV/AIDS as Strong as Ever Dec 01 2016
Is Corning Incorporated (GLW) the Right Stock for Your Portfolio? Nov 30 2016
MYLAN N.V. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material... Nov 29 2016
Mallinckrodt Earnings Top, But Stock Dives On Guidance Nov 29 2016
Do Hedge Funds Love Discover Financial Services (DFS)? Nov 29 2016
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Nov 29 2016
How to buy the biggest losers Nov 28 2016
Mylan Signs Sub-license Agreement with the Medicines Patent Pool to Increase Access to Hepatitis C... Nov 28 2016
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of... Nov 25 2016
Hedge Funds Continue to Ditch Mylan NV (MYL) Nov 24 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)